$66.8 Million is the total value of HealthInvest Partners AB's 17 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 133.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $8,946,000 | -54.3% | 685,000 | -54.9% | 13.40% | -27.7% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $8,934,000 | -45.3% | 335,000 | -36.8% | 13.38% | -13.5% |
| ARAY | Sell | ACCURAY INC | $7,347,000 | -29.3% | 1,860,000 | -19.1% | 11.00% | +11.7% |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $7,091,000 | – | 185,000 | +100.0% | 10.62% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $6,407,000 | – | 1,765,000 | +100.0% | 9.60% | – |
| LCI | New | LANNET INC | $5,325,000 | – | 1,775,000 | +100.0% | 7.98% | – |
| UTMD | New | UTAH MED PRODS INC | $3,899,000 | – | 42,000 | +100.0% | 5.84% | – |
| ZGNX | New | ZOGENIX INC | $3,342,000 | – | 220,000 | +100.0% | 5.01% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $2,722,000 | – | 310,000 | +100.0% | 4.08% | – |
| EOLS | New | EVOLUS INC | $2,286,000 | – | 300,000 | +100.0% | 3.42% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $1,672,000 | – | 14,000 | +100.0% | 2.50% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $1,657,000 | -83.1% | 28,000 | -81.0% | 2.48% | -73.3% |
| ABBV | Sell | ABBVIE INC | $1,618,000 | -83.1% | 15,000 | -82.4% | 2.42% | -73.3% |
| MCK | Sell | MCKESSON CORP | $1,595,000 | -84.0% | 8,000 | -84.6% | 2.39% | -74.6% |
| CAH | Sell | CARDINAL HEALTH INC | $1,583,000 | -83.7% | 32,000 | -81.2% | 2.37% | -74.2% |
| URGN | New | UROGEN PHARMA LTD | $1,262,000 | – | 75,000 | +100.0% | 1.89% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $1,077,000 | – | 270,000 | +100.0% | 1.61% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -41,000 | -100.0% | -9.21% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -52,000 | -100.0% | -9.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.